What's new? Log in Free sign up

T. Rowe Price Quantitative Management Funds NPORT-PT. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund (Sep 2024 report)

Filed: 26 Nov 24, 12:34pm

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

September

30,

2024

(Unaudited)

1

Portfolio

of

Investments

‡

Shares

$

Value

(Cost

and

value

in

$000s)

‡

COMMON

STOCKS

99.6%

COMMUNICATION

SERVICES

1.7%

Diversified

Telecommunication

Services

0.3%

GCI

Liberty,

Class

A,

EC (1)(2)

547,999‌

—‌

Iridium

Communications

998,414‌

30,402‌

30,402‌

Entertainment

0.9%

Endeavor

Group

Holdings,

Class

A (3)

1,360,313‌

38,851‌

TKO

Group

Holdings (2)

296,980‌

36,739‌

75,590‌

Interactive

Media

&

Services

0.1%

Cars.com (2)

563,839‌

9,450‌

9,450‌

Media

0.4%

Nexstar

Media

Group

202,408‌

33,468‌

Thryv

Holdings (2)

304,525‌

5,247‌

38,715‌

Total

Communication

Services

154,157‌

CONSUMER

DISCRETIONARY

14.5%

Automobile

Components

0.5%

Patrick

Industries

222,846‌

31,727‌

Visteon (2)

123,492‌

11,761‌

43,488‌

Broadline

Retail

0.2%

Ollie's

Bargain

Outlet

Holdings (2)

150,051‌

14,585‌

14,585‌

Distributors

0.3%

Pool

71,922‌

27,100‌

27,100‌

Diversified

Consumer

Services

2.5%

Bright

Horizons

Family

Solutions (2)

336,964‌

47,219‌

Duolingo (2)

150,442‌

42,428‌

Grand

Canyon

Education (2)

213,515‌

30,287‌

H&R

Block

625,773‌

39,768‌

Laureate

Education

946,739‌

15,725‌

Stride (2)

486,218‌

41,479‌

216,906‌

Hotels,

Restaurants

&

Leisure

4.4%

Bloomin'

Brands

415,445‌

6,867‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

2

Shares

$

Value

(Cost

and

value

in

$000s)

‡

Boyd

Gaming

635,383‌

41,077‌

Cava

Group (2)

157,469‌

19,503‌

Choice

Hotels

International (3)

150,639‌

19,628‌

Churchill

Downs

223,449‌

30,213‌

Domino's

Pizza

72,999‌

31,400‌

Hilton

Grand

Vacations (2)

393,287‌

14,284‌

Light

&

Wonder (2)

590,585‌

53,584‌

Red

Rock

Resorts,

Class

A

195,974‌

10,669‌

Texas

Roadhouse

195,262‌

34,483‌

Travel

+

Leisure

246,875‌

11,376‌

United

Parks

&

Resorts (2)

168,935‌

8,548‌

Wingstop

203,771‌

84,785‌

Wynn

Resorts

157,985‌

15,148‌

381,565‌

Household

Durables

2.2%

Cavco

Industries (2)

74,124‌

31,743‌

Champion

Homes (2)

258,276‌

24,497‌

Green

Brick

Partners (2)

382,580‌

31,953‌

Installed

Building

Products (3)

143,130‌

35,249‌

Tempur

Sealy

International

874,113‌

47,727‌

TopBuild (2)

46,020‌

18,721‌

189,890‌

Leisure

Products

0.5%

Brunswick

130,980‌

10,979‌

Mattel (2)

1,592,362‌

30,334‌

41,313‌

Specialty

Retail

3.2%

Abercrombie

&

Fitch,

Class

A (2)

351,757‌

49,211‌

Academy

Sports

&

Outdoors (3)

292,628‌

17,078‌

Asbury

Automotive

Group (2)

90,266‌

21,537‌

Carvana (2)

174,530‌

30,387‌

Dick's

Sporting

Goods

121,578‌

25,373‌

Group

1

Automotive

64,155‌

24,574‌

Murphy

USA

169,250‌

83,418‌

Valvoline (2)

628,189‌

26,290‌

277,868‌

Textiles,

Apparel

&

Luxury

Goods

0.7%

Crocs (2)

130,829‌

18,945‌

Deckers

Outdoor (2)

242,268‌

38,630‌

57,575‌

Total

Consumer

Discretionary

1,250,290‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

3

Shares

$

Value

(Cost

and

value

in

$000s)

‡

CONSUMER

STAPLES

4.3%

Beverages

0.8%

Coca-Cola

Consolidated

50,895‌

66,998‌

66,998‌

Consumer

Staples

Distribution

&

Retail

1.7%

Casey's

General

Stores

92,879‌

34,895‌

Performance

Food

Group (2)

391,307‌

30,667‌

Sprouts

Farmers

Market (2)

747,225‌

82,501‌

148,063‌

Food

Products

0.9%

Post

Holdings (2)

427,535‌

49,487‌

Simply

Good

Foods (2)

444,931‌

15,470‌

Vital

Farms (2)

320,900‌

11,254‌

76,211‌

Personal

Care

Products

0.9%

BellRing

Brands (2)

656,564‌

39,867‌

elf

Beauty (2)

210,711‌

22,974‌

Inter

Parfums

97,499‌

12,624‌

75,465‌

Total

Consumer

Staples

366,737‌

ENERGY

4.4%

Energy

Equipment

&

Services

1.8%

Expro

Group

Holdings (2)

406,182‌

6,974‌

Liberty

Energy

648,210‌

12,374‌

Noble

309,399‌

11,182‌

TechnipFMC

1,534,052‌

40,238‌

Tidewater (2)

309,997‌

22,255‌

Weatherford

International

742,545‌

63,057‌

156,080‌

Oil,

Gas

&

Consumable

Fuels

2.6%

Centrus

Energy,

Class

A (2)(3)

222,404‌

12,199‌

CNX

Resources (2)

790,038‌

25,732‌

CONSOL

Energy

195,999‌

20,511‌

Dorian

LPG

169,941‌

5,849‌

Gulfport

Energy (2)

86,287‌

13,060‌

Matador

Resources

700,653‌

34,626‌

PBF

Energy,

Class

A

100,229‌

3,102‌

Permian

Resources

1,177,400‌

16,025‌

Range

Resources

409,421‌

12,594‌

SM

Energy

578,794‌

23,134‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

4

Shares

$

Value

(Cost

and

value

in

$000s)

‡

Southwestern

Energy (2)

2,077,129‌

14,768‌

Viper

Energy

978,967‌

44,161‌

225,761‌

Total

Energy

381,841‌

FINANCIALS

6.4%

Banks

1.0%

Bancorp (2)

622,631‌

33,310‌

First

BanCorp

Puerto

Rico

1,445,058‌

30,592‌

ServisFirst

Bancshares

268,338‌

21,588‌

85,490‌

Capital

Markets

1.5%

Blue

Owl

Capital (3)

1,851,636‌

35,848‌

Donnelley

Financial

Solutions (2)

412,805‌

27,175‌

Hamilton

Lane,

Class

A

129,205‌

21,757‌

LPL

Financial

Holdings

73,220‌

17,033‌

StoneX

Group (2)

329,412‌

26,972‌

128,785‌

Financial

Services

1.6%

Euronet

Worldwide (2)

279,243‌

27,709‌

EVERTEC

454,082‌

15,389‌

Mr

Cooper

Group (2)

426,700‌

39,333‌

Payoneer

Global (2)

5,200,591‌

39,160‌

Shift4

Payments,

Class

A (2)(3)

179,984‌

15,947‌

137,538‌

Insurance

2.3%

Baldwin

Insurance

Group (2)

215,780‌

10,746‌

Bowhead

Specialty

Holdings (2)

93,843‌

2,628‌

Kinsale

Capital

Group

29,258‌

13,622‌

Oscar

Health,

Class

A (2)

1,099,307‌

23,316‌

Palomar

Holdings (2)

196,372‌

18,590‌

Primerica

169,748‌

45,009‌

RLI

167,393‌

25,942‌

Ryan

Specialty

Holdings

505,871‌

33,585‌

Skyward

Specialty

Insurance

Group (2)

536,875‌

21,867‌

TWFG (2)

178,490‌

4,841‌

200,146‌

Total

Financials

551,959‌

HEALTH

CARE

22.5%

Biotechnology

11.3%

ACADIA

Pharmaceuticals (2)

356,143‌

5,478‌

ADMA

Biologics (2)

1,527,417‌

30,533‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

5

Shares

$

Value

(Cost

and

value

in

$000s)

‡

Agios

Pharmaceuticals (2)

339,182‌

15,070‌

Akero

Therapeutics (2)

328,392‌

9,422‌

Alkermes (2)

1,042,009‌

29,166‌

Amicus

Therapeutics (2)

917,177‌

9,795‌

Arcellx (2)

177,697‌

14,839‌

Avidity

Biosciences (2)

789,866‌

36,279‌

Biohaven (2)

738,720‌

36,914‌

Blueprint

Medicines (2)

367,159‌

33,962‌

Bridgebio

Pharma (2)

559,362‌

14,241‌

Catalyst

Pharmaceuticals (2)

899,586‌

17,884‌

Celldex

Therapeutics (2)

284,144‌

9,658‌

Crinetics

Pharmaceuticals (2)

559,253‌

28,578‌

Cytokinetics (2)

610,564‌

32,238‌

Day

One

Biopharmaceuticals (2)(3)

233,998‌

3,260‌

Denali

Therapeutics (2)

549,214‌

15,999‌

Disc

Medicine (2)

126,605‌

6,221‌

Dyne

Therapeutics (2)

322,173‌

11,572‌

Exact

Sciences (2)(3)

418,017‌

28,475‌

Exelixis (2)

1,351,635‌

35,075‌

Halozyme

Therapeutics (2)

928,924‌

53,172‌

Ideaya

Biosciences (2)

433,080‌

13,720‌

IGM

Biosciences (2)(3)

139,572‌

2,309‌

Immunovant (2)

198,082‌

5,647‌

Insmed (2)

1,003,527‌

73,257‌

Intellia

Therapeutics (2)

327,938‌

6,739‌

Ionis

Pharmaceuticals (2)

609,746‌

24,426‌

Iovance

Biotherapeutics (2)

838,121‌

7,870‌

Keros

Therapeutics (2)

237,374‌

13,784‌

Krystal

Biotech (2)

111,833‌

20,357‌

Kymera

Therapeutics (2)

570,774‌

27,015‌

Madrigal

Pharmaceuticals (2)

59,805‌

12,692‌

Merus (2)

177,571‌

8,871‌

Mirum

Pharmaceuticals (2)(3)

161,900‌

6,314‌

Monte

Rosa

Therapeutics (2)(3)

536,436‌

2,843‌

MoonLake

Immunotherapeutics (2)

299,157‌

15,084‌

Natera (2)

193,118‌

24,516‌

Neurocrine

Biosciences (2)

161,073‌

18,559‌

Nurix

Therapeutics (2)

492,854‌

11,074‌

Nuvalent,

Class

A (2)

145,642‌

14,899‌

Praxis

Precision

Medicines (2)

137,947‌

7,937‌

Prothena (2)

411,507‌

6,885‌

PTC

Therapeutics (2)

396,172‌

14,698‌

Relay

Therapeutics (2)

466,283‌

3,301‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

6

Shares

$

Value

(Cost

and

value

in

$000s)

‡

Replimune

Group (2)

1,338,426‌

14,669‌

REVOLUTION

Medicines (2)

401,139‌

18,192‌

Rhythm

Pharmaceuticals (2)

195,801‌

10,258‌

Rocket

Pharmaceuticals (2)

281,431‌

5,198‌

Scholar

Rock,

Warrants,

12/31/25,

Acquisition

Date:

6/17/22,

Cost $— (2)(4)

22,712‌

58‌

Scholar

Rock

Holding (2)(3)

624,535‌

5,003‌

Soleno

Therapeutics (2)

51,800‌

2,615‌

SpringWorks

Therapeutics (2)

207,631‌

6,653‌

Ultragenyx

Pharmaceutical (2)

361,644‌

20,089‌

Vaxcyte (2)

411,954‌

47,074‌

Vera

Therapeutics (2)

455,667‌

20,141‌

Xencor (2)

473,095‌

9,514‌

980,092‌

Health

Care

Equipment

&

Supplies

3.9%

CONMED

98,182‌

7,061‌

Globus

Medical,

Class

A (2)

748,430‌

53,543‌

Haemonetics (2)

224,827‌

18,072‌

Inari

Medical (2)

104,441‌

4,307‌

Lantheus

Holdings (2)

551,392‌

60,515‌

LeMaitre

Vascular

211,096‌

19,609‌

Merit

Medical

Systems (2)

554,082‌

54,760‌

Penumbra (2)

86,137‌

16,737‌

PROCEPT

BioRobotics (2)

179,977‌

14,420‌

STERIS

140,069‌

33,972‌

TransMedics

Group (2)

186,162‌

29,227‌

UFP

Technologies (2)

85,627‌

27,118‌

339,341‌

Health

Care

Providers

&

Services

5.2%

Addus

HomeCare (2)

167,759‌

22,317‌

CorVel (2)

157,634‌

51,529‌

Encompass

Health

747,431‌

72,232‌

Ensign

Group

589,094‌

84,723‌

Guardant

Health (2)

462,247‌

10,604‌

Molina

Healthcare (2)

149,404‌

51,479‌

NeoGenomics (2)

272,915‌

4,025‌

Option

Care

Health (2)

1,800,052‌

56,342‌

RadNet (2)

257,101‌

17,840‌

Select

Medical

Holdings

560,483‌

19,544‌

Tenet

Healthcare (2)

395,860‌

65,792‌

456,427‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

7

Shares

$

Value

(Cost

and

value

in

$000s)

‡

Health

Care

Technology

0.1%

Evolent

Health,

Class

A (2)

461,660‌

13,056‌

13,056‌

Life

Sciences

Tools

&

Services

0.9%

10X

Genomics,

Class

A (2)

434,403‌

9,809‌

Charles

River

Laboratories

International (2)

75,457‌

14,863‌

Medpace

Holdings (2)

49,987‌

16,686‌

Repligen (2)

182,519‌

27,162‌

West

Pharmaceutical

Services

36,970‌

11,097‌

79,617‌

Pharmaceuticals

1.1%

Amphastar

Pharmaceuticals (2)

425,055‌

20,628‌

Arvinas (2)

363,428‌

8,951‌

Intra-Cellular

Therapies (2)

456,611‌

33,410‌

Longboard

Pharmaceuticals (2)

182,616‌

6,087‌

Pliant

Therapeutics (2)

426,563‌

4,782‌

Prestige

Consumer

Healthcare (2)

301,176‌

21,715‌

95,573‌

Total

Health

Care

1,964,106‌

INDUSTRIALS

&

BUSINESS

SERVICES

22.9%

Aerospace

&

Defense

2.6%

Cadre

Holdings (3)

347,621‌

13,192‌

Curtiss-Wright

302,934‌

99,572‌

Leonardo

DRS (2)

1,482,859‌

41,846‌

Loar

Holdings (2)

125,663‌

9,373‌

Moog,

Class

A

22,590‌

4,564‌

Woodward

347,734‌

59,640‌

228,187‌

Air

Freight

&

Logistics

0.3%

GXO

Logistics (2)

534,313‌

27,822‌

27,822‌

Building

Products

3.4%

AAON

322,216‌

34,748‌

AZEK (2)

1,180,188‌

55,233‌

Builders

FirstSource (2)

92,664‌

17,964‌

CSW

Industrials

152,260‌

55,786‌

Griffon

288,316‌

20,182‌

Simpson

Manufacturing

283,370‌

54,200‌

UFP

Industries

425,023‌

55,767‌

293,880‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

8

Shares

$

Value

(Cost

and

value

in

$000s)

‡

Commercial

Services

&

Supplies

2.0%

Brink's

330,600‌

38,231‌

Casella

Waste

Systems,

Class

A (2)

549,905‌

54,710‌

Clean

Harbors (2)

197,544‌

47,748‌

MSA

Safety

177,205‌

31,426‌

172,115‌

Construction

&

Engineering

2.0%

API

Group (2)

1,567,050‌

51,744‌

Comfort

Systems

USA

41,753‌

16,298‌

Dycom

Industries (2)

56,600‌

11,156‌

EMCOR

Group

72,683‌

31,292‌

Sterling

Infrastructure (2)

172,914‌

25,076‌

WillScot

Holdings (2)

959,883‌

36,092‌

171,658‌

Electrical

Equipment

0.8%

Atkore

216,880‌

18,378‌

NEXTracker,

Class

A (2)

176,571‌

6,618‌

Vertiv

Holdings,

Class

A

441,527‌

43,928‌

68,924‌

Ground

Transportation

1.0%

ArcBest

39,097‌

4,240‌

Landstar

System

81,806‌

15,451‌

Saia (2)

108,425‌

47,410‌

XPO (2)

224,046‌

24,087‌

91,188‌

Machinery

4.3%

Atmus

Filtration

Technologies

978,400‌

36,719‌

Crane

245,708‌

38,891‌

Esab

181,026‌

19,245‌

Federal

Signal

529,746‌

49,510‌

Kadant

156,564‌

52,918‌

Lincoln

Electric

Holdings

171,059‌

32,847‌

RBC

Bearings (2)

86,507‌

25,898‌

SPX

Technologies (2)

377,522‌

60,200‌

Toro

74,853‌

6,492‌

Watts

Water

Technologies,

Class

A

242,734‌

50,292‌

373,012‌

Marine

Transportation

0.2%

Kirby (2)

143,800‌

17,605‌

17,605‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

9

Shares

$

Value

(Cost

and

value

in

$000s)

‡

Professional

Services

4.0%

Booz

Allen

Hamilton

Holding

338,204‌

55,046‌

Broadridge

Financial

Solutions

110,102‌

23,675‌

CACI

International,

Class

A (2)

132,366‌

66,787‌

CBIZ (2)

562,852‌

37,874‌

ExlService

Holdings (2)

1,272,054‌

48,529‌

First

Advantage (2)

493,888‌

9,804‌

FTI

Consulting (2)

185,478‌

42,207‌

TriNet

Group

166,480‌

16,144‌

Verra

Mobility (2)

1,838,454‌

51,127‌

351,193‌

Trading

Companies

&

Distributors

2.3%

Applied

Industrial

Technologies

51,200‌

11,424‌

Boise

Cascade

202,346‌

28,527‌

Core

&

Main,

Class

A (2)

337,365‌

14,979‌

FTAI

Aviation

646,192‌

85,879‌

Herc

Holdings

60,096‌

9,581‌

SiteOne

Landscape

Supply (2)

212,124‌

32,011‌

Watsco

43,264‌

21,281‌

203,682‌

Total

Industrials

&

Business

Services

1,999,266‌

INFORMATION

TECHNOLOGY

17.7%

Communications

Equipment

0.1%

Extreme

Networks (2)

511,305‌

7,685‌

7,685‌

Electronic

Equipment,

Instruments

&

Components

3.5%

Advanced

Energy

Industries

235,620‌

24,797‌

Belden

421,535‌

49,374‌

ePlus (2)

110,900‌

10,906‌

Fabrinet (2)

307,469‌

72,698‌

Littelfuse

36,977‌

9,808‌

Novanta (2)

324,400‌

58,042‌

Teledyne

Technologies (2)

90,191‌

39,473‌

Vontier

1,176,382‌

39,691‌

Zebra

Technologies,

Class

A (2)

9,263‌

3,430‌

308,219‌

IT

Services

0.9%

ASGN (2)

241,519‌

22,517‌

Gartner (2)

40,602‌

20,575‌

Globant (2)

111,279‌

22,049‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

10

Shares

$

Value

(Cost

and

value

in

$000s)

‡

Kyndryl

Holdings (2)

390,388‌

8,971‌

74,112‌

Semiconductors

&

Semiconductor

Equipment

4.3%

Axcelis

Technologies (2)

394,758‌

41,390‌

Cirrus

Logic (2)

278,495‌

34,592‌

Diodes (2)

440,412‌

28,226‌

Entegris

120,270‌

13,534‌

FormFactor (2)

385,604‌

17,738‌

Kulicke

&

Soffa

Industries

270,345‌

12,201‌

MACOM

Technology

Solutions

Holdings (2)

363,965‌

40,495‌

MKS

Instruments

213,356‌

23,194‌

Monolithic

Power

Systems

35,737‌

33,039‌

Onto

Innovation (2)

330,818‌

68,665‌

Photronics (2)

776,383‌

19,223‌

Rambus (2)

727,862‌

30,730‌

Veeco

Instruments (2)

341,150‌

11,302‌

374,329‌

Software

8.9%

A10

Networks

916,167‌

13,229‌

ACI

Worldwide (2)

605,858‌

30,838‌

Agilysys (2)

297,640‌

32,434‌

Appfolio,

Class

A (2)

75,059‌

17,669‌

Blackbaud (2)

293,849‌

24,883‌

Box,

Class

A (2)

656,171‌

21,476‌

Braze,

Class

A (2)

133,200‌

4,308‌

CommVault

Systems (2)

279,831‌

43,052‌

Descartes

Systems

Group (2)

598,232‌

61,594‌

DoubleVerify

Holdings (2)

1,282,680‌

21,600‌

Dynatrace (2)

290,463‌

15,531‌

Envestnet (2)(3)

162,806‌

10,195‌

Fair

Isaac (2)

23,493‌

45,659‌

Fortinet (2)

282,990‌

21,946‌

Informatica,

Class

A (2)

443,233‌

11,205‌

Manhattan

Associates (2)

155,177‌

43,664‌

MARA

Holdings (2)(3)

283,600‌

4,600‌

MicroStrategy,

Class

A (2)(3)

74,791‌

12,610‌

Nutanix,

Class

A (2)

722,437‌

42,804‌

PTC (2)

163,086‌

29,463‌

Q2

Holdings (2)

552,999‌

44,113‌

Qualys (2)

177,281‌

22,774‌

Rapid7 (2)

188,788‌

7,531‌

Sapiens

International

595,804‌

22,206‌

Smartsheet,

Class

A (2)

666,604‌

36,903‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

11

Shares

$

Value

(Cost

and

value

in

$000s)

‡

SPS

Commerce (2)

280,025‌

54,372‌

Tenable

Holdings (2)

470,922‌

19,082‌

Tyler

Technologies (2)

42,809‌

24,988‌

Zeta

Global

Holdings,

Class

A (2)

1,167,945‌

34,840‌

775,569‌

Technology

Hardware,

Storage

&

Peripherals

0.0%

Pure

Storage,

Class

A (2)

84,765‌

4,259‌

4,259‌

Total

Information

Technology

1,544,173‌

MATERIALS

4.3%

Chemicals

1.9%

Axalta

Coating

Systems (2)

1,050,037‌

38,001‌

Balchem

163,730‌

28,816‌

Cabot

331,010‌

36,997‌

Element

Solutions

945,950‌

25,692‌

Olin

547,456‌

26,267‌

RPM

International

99,200‌

12,003‌

167,776‌

Construction

Materials

0.6%

Eagle

Materials

183,880‌

52,893‌

52,893‌

Containers

&

Packaging

0.1%

Graphic

Packaging

Holding

244,431‌

7,233‌

7,233‌

Metals

&

Mining

1.0%

Alpha

Metallurgical

Resources

79,193‌

18,704‌

ATI (2)

821,387‌

54,959‌

Warrior

Met

Coal

186,419‌

11,912‌

85,575‌

Paper

&

Forest

Products

0.7%

Louisiana-Pacific

538,304‌

57,846‌

57,846‌

Total

Materials

371,323‌

REAL

ESTATE

0.7%

Industrial

Real

Estate

Investment

Trusts

0.5%

First

Industrial

Realty

Trust,

REIT

416,650‌

23,324‌

Rexford

Industrial

Realty,

REIT

229,079‌

11,525‌

Terreno

Realty,

REIT

161,166‌

10,771‌

45,620‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

12

Shares

$

Value

(Cost

and

value

in

$000s)

‡

Residential

Real

Estate

Investment

Trusts

0.2%

Equity

LifeStyle

Properties,

REIT

202,506‌

14,447‌

14,447‌

Total

Real

Estate

60,067‌

UTILITIES

0.2%

Independent

Power

&

Renewable

Electricity

Producers

0.2%

Ormat

Technologies

242,046‌

18,623‌

Total

Utilities

18,623‌

Total

Common

Stocks

(Cost

$5,650,318)

8,662,542‌

SHORT-TERM

INVESTMENTS

0.4%

Money

Market

Funds

0.4%

T.

Rowe

Price

Government

Reserve

Fund,

4.97% (5)(6)

36,968,817‌

36,969‌

Total

Short-Term

Investments

(Cost

$36,969)

36,969‌

SECURITIES

LENDING

COLLATERAL

1.9%

INVESTMENTS

IN

A

POOLED

ACCOUNT

THROUGH

SECURITIES

LENDING

PROGRAM

WITH

STATE

STREET

BANK

AND

TRUST

COMPANY 1.9%

Money

Market

Funds 1.9%

T.

Rowe

Price

Government

Reserve

Fund,

4.97% (5)(6)

163,046,798‌

163,047‌

Total

Investments

in

a

Pooled

Account

through

Securities

Lending

Program

with

State

Street

Bank

and

Trust

Company

163,047‌

Total

Securities

Lending

Collateral

(Cost

$163,047)

163,047‌

Total

Investments

in

Securities

101.9%

(Cost

$5,850,334)

$

8,862,558‌

Other

Assets

Less

Liabilities

(1.9)%

(

165,612‌

)

Net

Assets

100.0%

$

8,696,946‌

‡

Shares

are

denominated

in

U.S.

dollars

unless

otherwise

noted.

(1)

Level

3

in

fair

value

hierarchy.

(2)

Non-income

producing

(3)

All

or

a

portion

of

this

security

is

on

loan

at

September

30,

2024.

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

13

.

.

.

.

.

.

.

.

.

.

(4)

Security

cannot

be

offered

for

public

resale

without

first

being

registered

under

the

Securities

Act

of

1933

and

related

rules

("restricted

security").

Acquisition

date

represents

the

day

on

which

an

enforceable

right

to

acquire

such

security

is

obtained

and

is

presented

along

with

related

cost

in

the

security

description.

The

fund

may

have

registration

rights

for

certain

restricted

securities.

Any

costs

related

to

such

registration

are

generally

borne

by

the

issuer.

The

aggregate

value

of

restricted

securities

(excluding

144A

holdings)

at

period

end

amounts

to

$58

and

represents

0.0%

of

net

assets.

(5)

Seven-day

yield

(6)

Affiliated

Companies

EC

Escrow

CUSIP;

represents

a

beneficial

interest

in

a

residual

pool

of

assets;

the

amount

and

timing

of

future

distributions,

if

any,

is

uncertain;

when

presented,

interest

rate

and

maturity

date

are

those

of

the

original

security.

REIT

A

domestic

Real

Estate

Investment

Trust

whose

distributions

pass-through

with

original

tax

character

to

the

shareholder

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

14

The

accompanying

notes

are

an

integral

part

of

this

Portfolio

of

Investments.

AFFILIATED

COMPANIES

($000s)

The

fund

may

invest

in

certain

securities

that

are

considered

affiliated

companies.

As

defined

by

the

1940

Act,

an

affiliated

company

is

one

in

which

the

fund

owns

5%

or

more

of

the

outstanding

voting

securities,

or

a

company

that

is

under

common

ownership

or

control.

The

following

securities

were

considered

affiliated

companies

for

all

or

some

portion

of

the

nine

months

ended

September

30,

2024.

Net

realized

gain

(loss),

investment

income,

change

in

net

unrealized

gain/loss,

and

purchase

and

sales

cost

reflect

all

activity

for

the

period

then

ended.

Affiliate

Net

Realized

Gain

(Loss)

Change

in

Net

Unrealized

Gain/Loss

Investment

Income

T.

Rowe

Price

Government

Reserve

Fund,

4.97%

$

—‌

$

—‌

$

2,425‌

++

Totals

$

—‌

#

$

—‌

$

2,425‌

+

Supplementary

Investment

Schedule

Affiliate

Value

12/31/23

Purchase

Cost

Sales

Cost

Value

09/30/24

T.

Rowe

Price

Government

Reserve

Fund,

4.97%

$

243,848‌

¤

¤

$

200,016‌

Total

$

200,016‌

^

#

Capital

gain

distributions

from

underlying

Price

funds

represented

$0

of

the

net

realized

gain

(loss).

++

Excludes

earnings

on

securities

lending

collateral,

which

are

subject

to

rebates

and

fees.

+

Investment

income

comprised

$2,425

of

dividend

income

and

$0

of

interest

income.

¤

Purchase

and

sale

information

not

shown

for

cash

management

funds.

^

The

cost

basis

of

investments

in

affiliated

companies

was

$200,016.

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

Unaudited

Notes

to

Portfolio

of

Investments

15

T.

Rowe

Price

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

(the

fund) is

registered

under

the

Investment

Company

Act

of

1940

(the

1940

Act)

as

an

open-end

management

investment

company

and

follows

accounting

and

reporting

guidance

of

the

Financial

Accounting

Standards

Board

Accounting

Standards

Codification

Topic

946.

The

accompanying

Portfolio

of

Investments

was

prepared

in

accordance

with

accounting

principles

generally

accepted

in

the

United

States

of

America

(GAAP).

For

additional

information

on

the

fund’s

significant

accounting

policies

and

investment

related

disclosures,

please

refer

to

the

fund’s

most

recent

semiannual

or

annual

shareholder

report

and

its

prospectus.

VALUATION

Fair

Value

The

fund’s

financial

instruments

are

valued

at

the

close

of

the

New

York

Stock

Exchange

(NYSE),

normally

4

p.m.

ET,

each

day

the

NYSE

is

open

for

business,

and

are

reported

at

fair

value,

which

GAAP

defines

as

the

price

that

would

be

received

to

sell

an

asset

or

paid

to

transfer

a

liability

in

an

orderly

transaction

between

market

participants

at

the

measurement

date. The fund’s

Board

of

Directors

(the

Board)

has

designated

T.

Rowe

Price

Associates,

Inc.

as

the

fund’s

valuation

designee

(Valuation

Designee).

Subject

to

oversight

by

the

Board,

the

Valuation

Designee

performs

the

following

functions

in

performing

fair

value

determinations:

assesses

and

manages

valuation

risks;

establishes

and

applies

fair

value

methodologies;

tests

fair

value

methodologies;

and

evaluates

pricing

vendors

and

pricing

agents.

The

duties

and

responsibilities

of

the

Valuation

Designee

are

performed

by

its

Valuation

Committee. The

Valuation

Designee provides

periodic

reporting

to

the

Board

on

valuation

matters.

Various

valuation

techniques

and

inputs

are

used

to

determine

the

fair

value

of

financial

instruments.

GAAP

establishes

the

following

fair

value

hierarchy

that

categorizes

the

inputs

used

to

measure

fair

value:

Level

1

–

quoted

prices

(unadjusted)

in

active

markets

for

identical

financial

instruments

that

the

fund

can

access

at

the

reporting

date

Level

2

–

inputs

other

than

Level

1

quoted

prices

that

are

observable,

either

directly

or

indirectly

(including,

but

not

limited

to,

quoted

prices

for

similar

financial

instruments

in

active

markets,

quoted

prices

for

identical

or

similar

financial

instruments

in

inactive

markets,

interest

rates

and

yield

curves,

implied

volatilities,

and

credit

spreads)

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

16

Level

3

–

unobservable

inputs

(including

the Valuation

Designee’s assumptions

in

determining

fair

value)

Observable

inputs

are

developed

using

market

data,

such

as

publicly

available

information

about

actual

events

or

transactions,

and

reflect

the

assumptions

that

market

participants

would

use

to

price

the

financial

instrument.

Unobservable

inputs

are

those

for

which

market

data

are

not

available

and

are

developed

using

the

best

information

available

about

the

assumptions

that

market

participants

would

use

to

price

the

financial

instrument.

GAAP

requires

valuation

techniques

to

maximize

the

use

of

relevant

observable

inputs

and

minimize

the

use

of

unobservable

inputs.

When

multiple

inputs

are

used

to

derive

fair

value,

the

financial

instrument

is

assigned

to

the

level

within

the

fair

value

hierarchy

based

on

the

lowest-level

input

that

is

significant

to

the

fair

value

of

the

financial

instrument.

Input

levels

are

not

necessarily

an

indication

of

the

risk

or

liquidity

associated

with

financial

instruments

at

that

level

but

rather

the

degree

of

judgment

used

in

determining

those

values.

Valuation

Techniques

Equity

securities,

including

exchange-traded

funds, listed

or

regularly

traded

on

a

securities

exchange

or

in

the

over-the-

counter

(OTC)

market

are

valued

at

the

last

quoted

sale

price

or,

for

certain

markets,

the

official

closing

price

at

the

time

the

valuations

are

made.

OTC

Bulletin

Board

securities

are

valued

at

the

mean

of

the

closing

bid

and

asked

prices.

A

security

that

is

listed

or

traded

on

more

than

one

exchange

is

valued

at

the

quotation

on

the

exchange

determined

to

be

the

primary

market

for

such

security.

Listed

securities

not

traded

on

a

particular

day

are

valued

at

the

mean

of

the

closing

bid

and

asked

prices

for

domestic

securities.

Investments

in

mutual

funds

are

valued

at

the

mutual

fund’s

closing

NAV

per

share

on

the

day

of

valuation.

Investments

for

which

market

quotations are

not

readily

available

or

deemed

unreliable

are

valued

at

fair

value

as

determined

in

good

faith

by

the

Valuation

Designee.

The

Valuation

Designee

has

adopted

methodologies

for

determining

the

fair

value

of

investments

for

which

market

quotations

are

not

readily

available

or

deemed

unreliable,

including

the

use

of

other

pricing

sources.

Factors

used

in

determining

fair

value

vary

by

type

of

investment

and

may

include

market

or

investment

specific

considerations.

The

Valuation

Designee typically

will

afford

greatest

weight

to

actual

prices

in

arm’s

length

transactions,

to

the

extent

they

represent

orderly

transactions

between

market

participants,

transaction

information

can

be

reliably

obtained,

and

prices

are

deemed

representative

of

fair

value.

However,

the

Valuation

Designee may

also

consider

other

valuation

methods

such

as

market-based

valuation

multiples;

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

17

a

discount

or

premium

from

market

value

of

a

similar,

freely

traded

security

of

the

same

issuer;

discounted

cash

flows;

yield

to

maturity;

or

some

combination.

Fair

value

determinations

are

reviewed

on

a

regular

basis.

Because

any

fair

value

determination

involves

a

significant

amount

of

judgment,

there

is

a

degree

of

subjectivity

inherent

in

such

pricing

decisions. Fair

value

prices

determined

by

the

Valuation

Designee could

differ

from

those

of

other

market

participants,

and

it

is

possible

that

the

fair

value

determined

for

a

security

may

be

materially

different

from

the

value

that

could

be

realized

upon

the

sale

of

that

security.

Valuation

Inputs

The

following

table

summarizes

the

fund’s

financial

instruments,

based

on

the

inputs

used

to

determine

their

fair

values

on

September

30,

2024

(for

further

detail

by

category,

please

refer

to

the

accompanying

Portfolio

of

Investments):

OTHER

MATTERS

Unpredictable environmental,

political,

social

and

economic

events,

including

but

not

limited

to,

environmental

or

natural

disasters,

war

and

conflict

(including

Russia’s

military

invasion

of

Ukraine

and

the

conflict

in

Israel,

Gaza

and

surrounding

areas),

terrorism,

geopolitical

developments

(including

trading

and

tariff

arrangements,

sanctions

and

cybersecurity

attacks),

and

public

health

epidemics

(including

the

global

outbreak

of

COVID-19)

and

similar

public

health

threats,

may

significantly

affect

the

economy

and

the

markets

and

issuers

in

which

a

fund

invests.

The

extent

and

duration

of

such

events

and

resulting

market

disruptions

cannot

be

predicted.

These

and

other

similar

events

may

cause

instability

across

global

markets,

including

reduced

liquidity

and

disruptions

in

trading

markets,

while

some

events

may

affect

certain

geographic

regions,

countries,

sectors,

and

industries

more

significantly

than

others,

and

exacerbate

other

pre-existing

political,

social,

and

economic

risks.

The

fund’s

($000s)

Level

1

Level

2

Level

3

Total

Value

Assets

Common

Stocks

$

8,662,484‌

$

58‌

$

—‌

$

8,662,542‌

Short-Term

Investments

36,969‌

—‌

—‌

36,969‌

Securities

Lending

Collateral

163,047‌

—‌

—‌

163,047‌

Total

$

8,862,500‌

$

58‌

$

—‌

$

8,862,558‌

T.

ROWE

PRICE

Integrated

U.S.

Small-Cap

Growth

Equity

Fund

18

performance

could

be

negatively

impacted

if

the

value

of

a

portfolio

holding

were

harmed

by

these

or

such

events.

Management

actively

monitors

the

risks

and

financial

impacts

arising

from

such

events.

F120-054Q3

09/24

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.